Cefixime 200mg + Clarithromycin 250mg Tablet in PCD pharma franchise in Hyderabad

Cefixime 200mg + Clarithromycin 250mg Tablet in pharmaceutical manufacturing company in Mumbai

Cefixime 200mg + Clarithromycin 250mg Tablet in antibiotic pharma franchise in Pune

Cefixime 200mg + Clarithromycin 250mg Tablet in pharma suppliers in Delhi

Cefixime 200mg + Clarithromycin 250mg Tablet in pharma export companies in Kolkata
Clariterm C Tablet in antibacterial pharma franchise opportunities in Bengaluru

Home/Products /cefixime-200mg-clarithromycin-250mg-tablets

About the Product

Description


Clariterm C Tablet: Premium Antibiotic Combination for Bulk Supply

Cafoli Lifecare's Clariterm C Tablet is a strategic, dual-action antibiotic formulation designed to maximize efficacy and ensure high prescription value in the anti-infective segment. This tablet combines Cefixime 200mg (a third-generation cephalosporin) and Clarithromycin 250mg (a potent macrolide) to deliver unparalleled broad-spectrum antibacterial activity.

Why Clariterm C Drives Franchise Success

The synergy between Cefixime (which inhibits bacterial cell wall synthesis) and Clarithromycin (which interferes with protein synthesis) provides a robust defense against a wide range of drug-resistant Gram-positive and Gram-negative bacteria. This makes Clariterm C Tablet highly preferred by doctors for complicated infections where mono-therapy may fail.

  • High Prescriber Confidence: This fixed-dose combination signals superior infection control, guaranteeing frequent prescription and consistent demand.

  • Targeted Segments: Essential for use in respiratory tract infections, ENT infections, and skin/soft tissue infections.

Bulk Supply & Wholesale Advantage

We specifically cater to bulk queries from wholesalers, super stockists, and hospital suppliers. We offer Clariterm C Tablet for PCD Pharma Franchise with guaranteed monopoly rights in your territory.

  • Assured Supply: Benefit from our zero-shortage guarantee for large-scale bulk orders.

  • Competitive Pricing: Get the best wholesale rates on this premium combination to maximize your profit margins.

  • Quality Assurance: Manufactured in WHO-GMP certified facilities, ensuring every batch meets the highest standards for hospital and institutional supply.

Secure the exclusive rights to Clariterm C Tablet and dominate the anti-infective segment with a product known for its superior clinical results.

Most patients tolerate this combination well. Some may experience nausea, diarrhea, abdominal pain, or headache. In rare cases, allergic reactions, skin rashes, or transient liver enzyme elevations may occur. Taking the tablet after food may help reduce gastric discomfort.

Clariterm C Tablet is indicated for the treatment of upper and lower respiratory tract infections, including pharyngitis, tonsillitis, sinusitis, bronchitis, and community-acquired pneumonia. It is also beneficial in ENT infections, skin and soft tissue infections, and certain cases of urinary tract infections when dual bacterial coverage is needed.

This medication should be used only under the prescription of a qualified physician. Complete the full course even if symptoms improve earlier to prevent bacterial resistance. Caution is advised in patients with a history of penicillin allergy, hepatic impairment, or kidney dysfunction.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

Why should medical distributors include Clariterm C Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of respiratory tract infections, throat infections, sinus infections, ear infections, urinary tract infections, and other bacterial infections. Cefixime 200mg is a broad-spectrum cephalosporin antibiotic effective against various bacterial infections Clarithromycin 250mg is a macrolide antibiotic that helps control susceptible respiratory and bacterial infections Together, they provide broad-spectrum antibacterial coverage, strengthening a reliable anti-infective portfolio.

What are the business opportunities for Clariterm C Tablet (Cefixime 200mg + Clarithromycin 250mg) in the PCD pharma franchise market?

Clariterm C Tablet has strong demand in the antibiotic and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on general medicine and infectious disease portfolios.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Clariterm C Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Clariterm C Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Clariterm C Tablet?

Wholesalers and medical agencies benefit from strong physician prescriptions, high seasonal demand for antibiotics, fast retail movement, reliable supply chain support, and good margins in anti-infective medicines.

How can I become a distributor or franchise partner for Clariterm C Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.